HANNAH LABOULIERE: Open Payments
NPI 1952133340 · LEVITTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,804 in 87 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $328 · 2025 $1,804
Food & beverage: $1,804
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $310 |
| ABBVIE INC. | 18 | $306 |
| Verona Pharma, Inc. | 5 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $114 |
| Novo Nordisk Inc | 6 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Astellas Pharma US Inc | 2 | $66 |
| PFIZER INC. | 4 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Lilly USA, LLC | 3 | $55 |
Products named: REXULTI, VRAYLAR, Ohtuvayre, CAPLYTA, UBRELVY, Veozah, SPRAVATO, FANAPT.
Industry payments across PA — which companies pay providers there.
